FamiCord AG (VTIAF)
3.10
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
FamiCord Research and Development Expense (Annual) : 0.948M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.948M |
| December 31, 2024 | 2.155M |
| December 31, 2023 | 4.661M |
| December 31, 2022 | 3.620M |
| December 31, 2021 | 0.9586M |
| December 31, 2020 | 0.5745M |
| December 31, 2019 | 0.544M |
| December 31, 2018 | 0.5545M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 |
| Date | Value |
|---|---|
| December 31, 2014 | 0.0915M |
| December 31, 2013 | 0.2058M |
| December 31, 2012 | 0.551M |
| December 31, 2011 | 0.413M |
| December 31, 2010 | 0.5492M |
| December 31, 2009 | 0.0973M |
| December 31, 2008 | 0.3219M |
| December 31, 2007 | 0.1205M |
| December 31, 2006 | 0.0389M |
| December 31, 2005 | 0.118M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Fresenius Medical Care AG | 178.29M |
| Global Cord Blood Corp. | -- |
| Cryo-Cell International, Inc. | 0.3763M |
| Rhön-Klinikum AG | -- |
| Cordlife Group Ltd. | -- |